NAME AND SURNAME | THE NAME OF THE EVENT | CITY, COUNTRY | DATE | TITLE OF PRESENTATION/POSTER |
---|---|---|---|---|
Georges Bedran | 68th ASMS Conference on Mass Spectrometry and Allied Topics | online | 31.05-04.06.2020 | poster: Proteogenomics meta analysis for unraveling the sources of MHC class I neoantigens in cancer |
Javier Alfaro | FORTRESS2020. Forum for Translational Research in Sarcoma | Essen, Germany | 23-24.01.2020 | poster: Integrative-omics of UPS and strategies for neoantigen discovery for personalized immunotherapeutics |
Katarzyna Dziubek | Science: Polish Perspectives (SPP) Conference 2019 | Cambridge, UK | 08-09.11.2019 | poster: Tumour intrinsic PD-1/PD-L1 signalling in canine osteosarcoma cell lines as a model for human disease |
Fiona Lickiss | Edinburgh Doors Open Day | Edinburgh, UK | 28-29.09.2019 | presentation: International efforts to improve brain cancer survival |
Małgorzata Kogut | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | poster: Blocking the TNF-TNFR2 interactions – a promising cancer treatment |
Zuzanna Urban-Wojciuk | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | poster: Characterization of tumour-infiltrating lymphocytes from non-small cel lung cancer |
Sara Mikac | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | poster: Nrf2 role in immune surveillance |
Artur Pirog | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | poster: Implementation and application of an external high performance data acquisition system on Orbitrap mass spectrometers |
Naomi Uwugiaren | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | poster: Proteomic Analysis of Barrett’s Esophagus Cells |
Jacek Kowalski | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | poster: Immunohistochemical study of tumour-infiltrating lymphocytes in non-small cell lung cance |
Elif Gediz Kocaoglan | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | poster: Enzymatic production of lipid A using synthetic biology approaches |
Katarzyna Dziubek | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | poster: Investigating tumour intrinsic PD-1/PD-L1 signalling in canine osteosarcoma cell lines as a spontaneous model of human disease |
Robin Fahraeus | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | presentation: The immune suppressive mechanism of the Epstein-Barr virus-encoded EBNA1 is oncogenic |
Ted Hupp | Molecular Biology and Immunology of Cancer – R&D perspectives: ScanBalt Forum 2019 | Gdansk, Poland | 24-25.09.2019 | presentation: Developing interferon signalling models in human cancer |
Javier Alfaro | Single Molecule Protein Sequencing 2019 | Jerusalem, Israel | 16.09.2019 | presentation: The need for new proteomics technologies in cancer vaccine science |
Małgorzata Kogut | 25th POLISH PEPTIDE SYMPOSIUM | Wojanów, Poland | 08-12.09.2019 | poster: Blocking the TNF-TNFR2 interactions – a promising cancer treatment |
Tsabieh Bilal | 1st Nanobody Symposium | Bonn, Germany | 04-07.09.2019 | poster: Computational prediction of nanobody binding: targeting fructose 1, 6-bisphosphate aldolase |
Katarzyna Dziubek | BioLab Alumni Symposium | Warsaw, Poland | 26-27.07.2019 | poster: Investigating tumour intrinsic PD-1/PD-L1 signalling in canine osteosarcoma cell lines as a spontaneous model of human disease |
Elif Gediz Kocaoglan | International Synthetic and Systems Biology Summer School (SSBSS) | Pisa, Italy | 22-26.07.2019 | poster: Enzymatic production of lipid A using synthetic biology approaches |
Marcos Mayordomo | 13th Mass Spectrometry School in Biotechnology and Medicine (MSBM) | Dubrovnik, Croatia | 07-13.07.2019 | poster: Proteogenomics Identifies Common Drugabble Pathways in Undifferentiated Pleomorphic Sarcoma |
Mikołaj Kocikowski | 13th Mass Spectrometry School in Biotechnology and Medicine (MSBM) | Dubrovnik, Croatia | 07-13.07.2019 | poster: Dogizing Antibodies Against PD1 and CD20 |
Georges Bedran | 13th Mass Spectrometry School in Biotechnology and Medicine (MSBM) | Dubrovnik, Croatia | 07-13.07.2019 | poster: Computational and Experimental Approaches to Determine the Immuno-peptidome Landscape on Cancer Cells |
Geoffrey Knight | 13th Mass Spectrometry School in Biotechnology and Medicine (MSBM) | Dubrovnik, Croatia | 07-13.07.2019 | poster: Mass Spectrometry in Analytical Application to Relevant Cytochemical Species |
Irena Dapic | 13th Mass Spectrometry School in Biotechnology and Medicine (MSBM) | Dubrovnik, Croatia | 07-13.07.2019 | poster: Mass Spectrometry in Analytical Application to Relevant Cytochemical Species |
Javier Alfaro | 13th Mass Spectrometry School in Biotechnology and Medicine (MSBM) | Dubrovnik, Croatia | 07-13.07.2019 | presentation: Cancer Vaccine Bioinformatics Research Group |
Natalia Marek-Trzonkowska | XVII Congress of the Association of the National Council of EU Research Project Coordinators (KRAB) | Gdansk, Poland | 13-14.06.2019 | presentation: International Centre for Cancer Vaccine Science – immunology, molecular biology and proteomics in research on new cancer therapies |
Naomi Uwugiaren | 67th American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics | Atlanta, USA | 02-06.06.2019 | poster: Protein analysis of glioblastoma formalin-fixed paraffin-embedded tissues |
Sachin Kote | 67th American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics | Atlanta, USA | 02-06.06.2019 | poster: Comparison of peptide separation methods to maximize the mutational landscape in a cell line momdel system used for neoantigen discovery |
Marcos Mayordomo | 67th American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics | Atlanta, USA | 02-06.06.2019 | poster: Proteogenomics Identifies Common Drugabble Pathways in Undifferentiated Pleomorphic Sarcoma |
Javier Alfaro | EMBO Workshop Antigen processing and presentation 10 (APP 10) | Paris, France | 30.05-02.06.2019 | poster: Bioinformatics strategies for the comprehensive characterization of antigen processing and presentation |
Georges Bedran | EMBO Workshop Antigen processing and presentation 10 (APP 10) | Paris, France | 30.05-02.06.2019 | poster: Computational and Experimental Approaches to Determine the Immuno-peptidome Landscape on Cancer Cells |
Sara Mikac | EMBO Workshop Antigen processing and presentation 10 (APP 10) | Paris, France | 30.05-02.06.2019 | poster: MHC class I regulation in response to dsRNA stress |
Alicja Sznarkowska | EMBO Workshop Antigen processing and presentation 10 (APP 10) | Paris, France | 30.05-02.06.2019 | poster: MHC class I regulation in response to dsRNA stress |
Ewa Sroka | EMBO Workshop Antigen processing and presentation 10 (APP 10) | Paris, France | 30.05-02.06.2019 | poster: Alternative sources of antigenic peptides for self and nonself recognition |
Javier Alfaro | Cambridge Oesophageal Meeting | Cambridge, UK | 07-09.04.2019 | presentation: Proteogenomics applications in Oesophageal Cancer |
Katarzyna Dziubek | American Association for Cancer Research Annual Meeting 2019 | Atlanta, USA | 29.03-03.04.2019 | poster: Investigation of tumour intrinsic PD-1/PD-L1 in canine urothelial carcinomas as a spontaneous translational model for human invasive bladder cancer |
David Goodlett | CMSC 2019 | Olomouc, Czech Republic | 27-29.03.2019 | presentation: Lipid A as a therapeutic and diagnostic |
Ted Hupp | ENOCH Research Meeting I | Olomouc, Czech Republic | 20-21.03.2019 | presentation: Identifying Novel Oncogenic Signalling Pathways in Oesophageal Cancer Progression |
Elżbieta Chruściel | EMBL Course: “Genome Engineering: CRISPR/Cas” | Heidelberg, Germany | 17-23.03.2019 | poster: Type I interferons and cGAS-STING pathway in cancer |
Magdalena Pilch | Cancer Metastasis: The Role of Metabolism, Immunity and the Microenvironment | Florence, Italy | 15-19.03.2019 | poster: Down-regulation of MHC class I is associated with the IFITM1 expression in oesophageal adenocarcinoma progression |
Irena Dapic | 11th International Conference of Contemporary Oncology | Poznań, Poland | 13-15.03.2019 | poster: Protein analysis of glioblastoma formalin-fixed paraffin-embedded tissues |
Alicja Sznarkowska | 11th International Conference of Contemporary Oncology | Poznań, Poland | 13-15.03.2019 | poster: Nrf2 in non-small cell lung cancer: potential role in immune surveillance |
Sachin Kote | 11th International Conference of Contemporary Oncology | Poznań, Poland | 13-15.03.2019 | poster: p53 mutant cel line as a model for a neoantigen discovery pipeline |
Zuzanna Urban-Wójciuk | 11th International Conference of Contemporary Oncology | Poznań, Poland | 13-15.03.2019 | poster: The polyamine analog verlindamycin promotes differentiation and cell death in neuroblastoma |
Robin Fahraeus | Gordon Research Conference. Translation Machinery in Health and Disease | Galveston, USA | 17-22.02.2019 | presentation: Antigenic Peptides for the MHC Class I Pathway Are Derived from Pre-Spliced |
Małgorzata Kogut | II Pomeranian PhD students Conference BioMed Session 2018 (II Konferencja Doktorantów Pomorza) | Gdańsk, Poland | 07.12.2018 | poster: Blocking the TNF-TNFR2 interactions – a promising cancer treatment |
Robin Fahraeus | RNA and Disease | Uppsala, Sweden | 18-20.11.2018 | poster: Pre-mRNAs is the Origin of Neoantigens for the major histocompatibility complex class I pathway |
Robin Fahraeus | MDM2 | Florida, USA | 03-07.11.2018 | presentation: A novel pathway for viral induced oncogenesis |
Iolanda Alves | Fourth International Cancer Immunotherapy Conference | New York, USA | 29.09-03.10.2018 | poster: Sources of Antigenic Peptides for the MHC-I Pathway and its Significance for Viral Immune Evasion |
Ewa Sroka | Fourth International Cancer Immunotherapy Conference | New York, USA | 29.09-03.10.2018 | poster: Origins of neoantigens for the major histocompatibility complex class I pathway |
David Goodlett | Pacific Northwest National Laboratory | Richland, WA., USA | 02.10.2018 | presentation: Use of lipid A as a therapeutic and diagnostic |
Robin Fahraeus | Congress BIO2018 | Poland, Gdańsk | 18.09.2018 | presentation: Viral mRNA translation control: linking immune evasion with oncogenesis |
Sachin Kote | HUPP-HIPP Summer School | Madrid, Spain | 10-13.09.2018 | poster: p53 mutant cel line as a model for a neoantigen discovery pipeline |
David Goodlett | Institute of Microbiology, Academy of Sciences of the Czech Republic | Italy, Florence | 06.09.2018 | poster: Rapid Targeted LC-MS/MS Assay for ESKAPE Pathogen Identification Direct from Biological Fluids |
David Goodlett | Institute of Microbiology, Academy of Sciences of the Czech Republic | Italy, Florence | 05.09.2018 | presentation: Identification of Bacteria by MALDI-TOF MS |
David Goodlett | Croatian Biophysics Society | Split, Croatia | 27.08.2018 | presentation: Identification of Bacteria by MALDI-TOF MS |
David Goodlett | Croatian Biophysics Society | Split, Croatia | 26.08.2018 | presentation: Longitudinal sampling in biomarker discovery |
David Goodlett | MSBM XII Summer School | Dubrovnik, Croatia | 12.07.2018 | presentation: Identification of Bacteria by MALDI-TOF MS |
Sachin Kote | MSBM XII Summer School | Dubrovnik, Croatia | 08-14.07.2018 | poster: p53 mutant cel line as a model for a neoantigen discovery pipeline |
Sachin Kote | Brain Tumors 2018 – From Biology to Therapy | Warsaw, Poland | 21-23.06.2018 | poster: Identifying clinically relevant receptors for antibody therapeutics |